📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Vishay Precision Group, Inc. engages in the precision measurement and sensing technologies business in the United States, Europe, Israel, Asia, and Canada.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding VPG

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Jim Simons Renaissance Technologies LLC	437.2K	$19.0M	0.03%	Mar 2026
Steve Cohen Point72 Asset Management	17.0K	$736K	0.00%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q2 2025

Confident Specific

Management repeatedly highlighted three consecutive quarters of sequential bookings growth, a 1.06 book-to-bill, and record adjusted gross margin in Weighing Solutions. They quantified tariff impact at $500k and gave specific cost reduction progress ($2.8M captured from $5M target).

Q3 2025

Mixed

Management expressed satisfaction with a 'solid quarter' and 'stable, moderately improved business environment,' but also highlighted softening in weighing solutions and defense project delays, using cautious language like 'softening' and 'delays.'

Q4 2025

Mixed

The CEO expressed optimism about recovery and growth initiatives ('we are fairly optimistic regarding the recovery'), but also acknowledged headwinds in Q4 gross margin and mixed trends in some end markets, while the CFO guided for lower Q1 revenue.

Q1 2026 latest

Confident Specific

Management described Q1 as a 'strong start' with revenue up 18% YoY and bookings at $102.1M, the highest since 2022. They provided specific Q2 revenue guidance ($85M-$90M) and a detailed three-year target model with explicit margin targets and cost reduction goals.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis strengthens after this call. Bookings surged to $102.1M (book-to-bill 1.21), the highest since 2022, driven by AI infrastructure and defense—areas where VPG has differentiated technology. The new three-year target model provides a clear roadmap for faster organic growth (8-10% CAGR) and margin expansion (EBITDA 18.5-20.5%), supported by a concrete cost reduction plan. Key risks remain: humanoid robot revenue is tiny and timing uncertain, and the company needs to sustain the booking momentum. Next quarter, watch whether the book-to-bill stays above 1.0 and whether humanoid Q2 revenue indeed more than doubles. Execution on the cost reduction program will be critical to achieving the target margins.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED VPG Q1 2026 revenue $84.4M, bookings $102.1M, book-to-bill 1.21.

Revenue & Profitability

Q1 2026 revenue was $84.4 million, up 18% year-over-year. GAAP net loss was $319,000 ($0.02 loss per diluted share). Adjusted net earnings were $907,000 ($0.07 diluted). Gross margin was 39%. Orders reached $102.1 million, a 26% sequential increase, driving a book-to-bill ratio of 1.21. For Q2, revenue guidance is $85 million to $90 million.

Outlook

Management expects continued positive booking trends into Q2, driven by AI infrastructure, semiconductor equipment, data centers, fiber optics, and defense. Despite macroeconomic uncertainty from geopolitical tensions, demand remains strong. The new target model projects 8%-10% compounded annual organic revenue growth over three years, with Sensors and Measurement Systems growing at or above that rate.

Growth Drivers

Key growth levers include AI adoption (precision resistors for semiconductor equipment and data center/fiber optics), humanoid robotics ($600k shipped in Q1, expected to double in Q2), and defense (avionics, military, space). Business development initiatives generated $10 million in Q1 orders, on track to meet the $45 million full-year target. Increased backlog in Sensor segment positions for continued growth.

Balance Sheet & CapEx

Q1 2026 CapEx was $3 million. For full-year 2026, CapEx is forecast at $14 million to $16 million (approximately 4%-5% of revenue). Investments support manufacturing footprint optimization, automation, and procurement efficiencies under the new COO-led operating structure. Hiring and training of manufacturing personnel are underway to support planned production ramps.

Margins

Gross margin in Q1 was 39%, improving from Q4. Adjusted operating margin was 1.9% after restructuring costs of $449,000 and stock-based compensation of $837,000. The updated three-year target model targets gross margin of 46.5%, operating margin of 14.5%-15.5%, and EBITDA margin of 18.5%-20.5%. The model includes $5 million annual incremental costs for new organizational structure and IT investments.

Key Risks

Management flagged ongoing macroeconomic uncertainty from geopolitical tensions. Unfavorable foreign exchange rates reduced adjusted operating margin by $800,000 sequentially and $1.3 million year-over-year. The precise timing and scale of humanoid robot production ramps remain unclear. Short visibility on customer orders was noted. The company assumes constant exchange rates for Q2 guidance.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-08-05

Orders and backlog remain strong, with Sensors segment leading growth and AI-related markets driving demand. Revenue was flat sequentially but up 12% year-over-year, while FX and ERP delays impacted profitability. Full-year double-digit revenue growth is expected, with cost savings and capacity expansion supporting future performance.

Q1 2026 Q1 2026 2026-05-12

Q1 2026 saw 18% revenue growth year-over-year, robust bookings, and improved margins, driven by strong demand in AI, defense, and data center markets. The new operating model targets higher growth and profitability, with significant investments in operational excellence and business development initiatives.

Q4 2025 Q4 2025 2026-02-11

Q4 2025 revenue grew 11% year-over-year with strong bookings and a book-to-bill above 1, led by Sensors. Gross margin was impacted by one-time items but is expected to improve, and organizational changes are underway to drive growth and efficiency.

Q3 2025 Q3 2025 2025-11-04

Q3 2025 saw revenue and margin growth, with strong sensor demand offsetting weighing solutions softness. Cost reductions and business development initiatives are on track, while defense project delays and FX headwinds present challenges.

Q2 2025 Q2 2025 2025-08-05

Q2 2025 saw 4.8% sequential revenue growth, record gross margin in Weighing Solutions, and strong cash flow. Bookings rose for the third straight quarter, cost savings are on track, and guidance for Q3 revenue is $73–$81 million.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.